Neurological, Inflammatory and Metabolic Effects of Acute Mushroom Intervention in Older Adults
NCT05594329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2023-05-23
Summary
This randomized crossover trial (RCT) investigates the acute effect (over a 6-hour period) of a meal containing varying serving sizes (doses) of freeze-dried oyster mushroom powder, on the cognitive behaviour and markers of metabolism and inflammation related to neuronal health in healthy adults aged 60-80 years old. The study will involve a screening visit and four testing visits, with a week interval between each. During the four testing visits, cognitive-mood battery tests will be taken at baseline and then at 2-, 4- and 6-hour intervals following the consumption of the intervention meal. Also, a blood draw will be taken at the end of each testing visit day to allow the determination of inflammatory, metabolic and neuronal markers.
Conditions
- Cognitive Change
- Mood
- Metabolism
- Inflammatory Response
- Satiety
Interventions
- OTHER
-
Instant noodle soup containing containing the equivalent of 2 servings (18.78g) of powdered Pleurotus oyster mushroom.
Ingredients: celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, dried Pleurotus oyster mushroom, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
- OTHER
-
Instant noodle soup containing containing the equivalent of 1 serving (9.39g) of powdered Pleurotus oyster mushroom.
Ingredients: cornflour, celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, dried Pleurotus oyster mushroom, maltodextrin, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
- OTHER
-
Instant noodle soup containing containing the equivalent of 0.5 serving (4.70g) of powdered Pleurotus oyster mushroom.
Ingredients: cornflour, celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, dried Pleurotus oyster mushroom, maltodextrin, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
- OTHER
-
Control instant noodle soup
Ingredients: cornflour, celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, maltodextrin, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
Sponsors & Collaborators
-
Mushroom Council
collaborator OTHER -
University of Reading
lead OTHER
Principal Investigators
-
Claire Williams, PhD · School of Psychology and Clinical Languages, University of Reading
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 60 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-15
- Primary Completion
- 2022-12-01
- Completion
- 2022-12-22
Countries
- United Kingdom
Study Locations
More Related Trials
-
Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis
NCT01259336 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Fluconazole in Children With Autism Spectrum Disorder
NCT00936182 ·Status: UNKNOWN ·Phase: NA
-
Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients
NCT02318524 ·Status: COMPLETED
-
Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)
NCT02387983 ·Status: COMPLETED ·Phase: PHASE1
-
POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
NCT00423267 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients
NCT04157465 ·Status: COMPLETED ·Phase: NA
-
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
NCT00841971 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of a Food Product Containing Mushroom Extracts (AndoSanTM) in Subjects with Colorectal Cancer-related Fatigue
NCT06599710 ·Status: RECRUITING ·Phase: NA
-
Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
NCT00048750 ·Status: TERMINATED ·Phase: PHASE3
-
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
NCT02180165 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
NCT00002533 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults.
NCT05822440 ·Status: COMPLETED ·Phase: PHASE1
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study
NCT07191756 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects
NCT03340597 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Antifungals on the Intestinal Microbiome - a Randomized, Controlled, Proof-of-concept Trial
NCT07295314 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis
NCT01125644 ·Status: UNKNOWN ·Phase: PHASE3
-
Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA
NCT03920527 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects
NCT01711827 ·Status: COMPLETED ·Phase: PHASE1
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
NCT07283497 ·Status: RECRUITING ·Phase: PHASE4
-
Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)
NCT00520234 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
NCT01782131 ·Status: COMPLETED ·Phase: PHASE3
-
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
NCT00083343 ·Status: COMPLETED ·Phase: PHASE2